A Prospective and Open-Label Study of the Effect on Proximal Tubular Function in Asian-American Patients Receiving Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) for HBV Treatment
Phase of Trial: Phase IV
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors New Discovery
- 31 Aug 2018 Biomarkers information updated
- 08 Jun 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 08 Jun 2015 Planned primary completion date changed from 1 Oct 2014 to 1 May 2016, as reported by ClinicalTrials.gov.